Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MIRA Pharmaceuticals, Inc. ( (MIRA) ) has issued an announcement.
On July 3, 2025, MIRA Pharmaceuticals, Inc. sold 1,550,741 shares of its common stock at an average price of $1.2981 per share, generating approximately $2.0 million in gross proceeds. The transaction was conducted through its at-the-market equity offering facility and facilitated by Rodman & Renshaw via the StockBlock platform, without the inclusion of any warrants.
The most recent analyst rating on (MIRA) stock is a Buy with a $17.00 price target. To see the full list of analyst forecasts on MIRA Pharmaceuticals, Inc. stock, see the MIRA Stock Forecast page.
More about MIRA Pharmaceuticals, Inc.
Average Trading Volume: 1,905,588
Technical Sentiment Signal: Hold
For detailed information about MIRA stock, go to TipRanks’ Stock Analysis page.